Basic Search  |  Summaries  |  Advanced SearchPenalty: £63,300,000
Year: 2022
Date: 21 July, 2022
Offence Group: competition-related offences
Offence Type: price-fixing or anti-competitive practices
Violation Description: Pfizer and Flynn were fined £63 million and £6.7 million respectively after a finding by the CMA that the companies illegally exploited their dominant market position to charge the NHS excessive prices for phenytoin sodium capsules, an anti-epilepsy medicine, with Pfizer stopping sale of its price regulated branded version and transferring the contract to Flynn who sold the same phenytoin as a generic price unregulated drug with over 1000% price increases.
Action Type: agency action
Agency: Competition and Markets Authority
HQ Country of Parent: United States
Ownership Structure of Parent: publicly traded
Major Industry of Parent: pharmaceuticals
Specific Industry of Parent: pharmaceuticals
Source of Data: (click here)